Volume 202 - Issue 4
Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives
Authors: Ching Jou Lim, Megan W-L Kwong and David C M Kong
Med J Aust 2015; 202 (4): 180. || doi: 10.5694/mja14.01422
Published online: 2 March 2015
Published online: 2 March 2015
In reply: Our focus was the providers’ perspectives, but we acknowledge the importance of the consumer alongside
In reply: We acknowledge the importance of the consumer in shared decision making regarding patient care. Our focus was to explore antibiotic prescribing practices from health care providers' perspectives,1 including workflow-related factors, in residential aged care facilities (RACFs).
We aimed to identify the potential for point-of-care tools in RACFs, among other interventions. Not surprisingly, a perception of consumer demand for antibiotics was reported, and this has been evident in other publications.2-4 Nevertheless, the views of consumers were outside the scope of our study.
Importantly, we remain interested in consumer perspectives on antibiotic use. Members of this research team are directly involved with consumer-based activities related to antibiotic prescribing, such as developing clinical care standards.
Competing interests
No relevant disclosures.
References
- Lim CJ, Kwong MW-L, Stuart RL, et al. Antibiotic prescribing practice in residential aged care facilities — health care providers' perspectives. Med J Aust 2014; 201: 101-105. _GoBack
- Consumers Health Forum of Australia. Community Quality Use of Medicines and Diagnostics Project. Consumer and general practice use of antibiotics: a consumer information and discussion paper. Canberra: CHF, 2011. 2
- McNulty CAM, Boyle P, Nichols T, et al. The public's attitudes to and compliance with antibiotics. J Antimicrob Chemother 2007; 60 Suppl 1: i63-i68. 3
- Coenen S, Michiels B, Renard D, et al. Antibiotic prescribing for acute cough: the effect of perceived patient demand. Br J Gen Pract 2006; 56: 183-190. lefthere
Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population
Hadar Mudrik-Zohar, Tim Cutfield, Susan Morpeth, Thomas Hills, Eamon Duffy, Laura J. Edwards, Allen C. Cheng, Steven Y. C. Tong
Birth prevalence, clinical sequelae, and management of congenital cytomegalovirus infections in Australia, 1999–2023: a national prospective study
Ece Egilmezer, Suzy M Teutsch, Carlos Nunez, Stuart T Hamilton, Adam W Bartlett, Pamela Palasanthiran, Elizabeth J Elliott, William D Rawlinson
Medication delivery and dispensing interval preferences of people who use antihypertensive medications in Australia: a survey study
Carissa Bonner, Michael A Fajardo, Rachael M Keast, Emily Atkins, Niamh Chapman, Kristie R Weir, Anthony Rodgers, Aletta E Schutte
Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021
Michelle KY Chen, Adrian Lim, Deshan F Sebaratnam
Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021
Aaron E Boyce, Tony Caccetta, Jo‐Ann See, Rosemary L Nixon AM